Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Nasal Endotoxin Challenge to Study Mucosal Inflammation in Patients With Asthma

NCT06270576 is registered in ClinicalTrials.gov with National Jewish Health as lead sponsor.

NCT NCT06270576
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06270576 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Nasal Endotoxin Challenge to Study Mucosal Inflammation in Patients With Asthma
Lead sponsor
National Jewish Health
Phase
Phase 1
Overall status
Not yet recruiting
Start date
April 30, 2024
Completion date
June 30, 2028
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

asthma, asthma; eosinophilic